Skip to content

Clinical trials

Observational Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Observational Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20114
20121
20133
20142
20152
20161
20172
20183
20192
20203
20215
20223
20232
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting10
Terminated7
Unknown status5
Withdrawn2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic6
City of Hope Medical Center5
Weill Medical College of Cornell University4
Alaunos Therapeutics2
National Cancer Institute (NCI)2
Washington University School of Medicine2
Al-Azhar University1
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Boston Scientific Corporation1
Cook Research Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma44
Pancreatic Neoplasms15
Carcinoma, Hepatocellular13
Liver Neoplasms13
Bile Duct Neoplasms8
Stomach Neoplasms7
Breast Neoplasms6
Colorectal Neoplasms6
Carcinoma, Renal Cell5
Colonic Neoplasms5

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.